The Insight Partners published latest research report on “Biopharmaceutical Tubing Market Size Report, Share, Trends, Growth & Forecast to 2028 - COVID-19 Impact and Global Analysis By Type and Application”,
The Insight Partners published latest research report on “Biopharmaceutical Tubing Market Size Report, Share, Trends, Growth & Forecast to 2028 - COVID-19 Impact and Global Analysis By Type and Application”, the global market is projected to reach USD 6,013.27 million by 2028 from USD 3,442.82 million in 2021; it is expected to grow at a CAGR of 8.3% from 2021 to 2028.
Request Sample PDF Brochure: https://www.theinsightpartners.com/sample/TIPRE00008648
Increase in life expectancy is leading to rise in geriatric population in the world. According to the World Health Organization (WHO), the global population share of people with age >60 would nearly double from 12% in 2015 to 22% in 2050. According to the United Nation’s World Population Ageing 2017 report, in 2017, there were 962 million people with age 60 or above in the world, and the number is expected to reach ~2.1 billion by 2050. In addition, according to the US Census Bureau, the number of people in the US with age 65 and above is anticipated to grow from 46 million in 2016 to more than 98 million by 2060, their population share would grow from ~15% to ~24% during this period. According to the United Nation’s World Population Ageing 2017 report, in 2017, Europe had the highest percentage of people over the age of 60 that is (25%). Other regions of the world are also experiencing accelerated ageing, and by 2050, all regions of the world except Africa will have approximately a quarter or more of their populations aged 60 and over. The geriatric population in the world is anticipated to reach US$ 1.4 billion, US$ 2.1 billion, and above US$ 3.1 billion by 2030, 2050, and 2100, respectively.
This rise in the elderly population has led to an increase in the geriatric ailments, thus generating a greater demand for diagnostic equipment and drug delivery systems. It is also resulting in the spike in incidence of urological conditions that require catheterization. Medical professionals are also encouraging self-catheterization to reduce the cost and period of hospitalization as well as to avert the risk of healthcare-associated infections (HAI). Aging is also a main factor that contributes to the increase in chronic diseases that might lead to the need for interventions that require admission to ICUs. Thus, rapid growth in the geriatric population is directly proportional to the rising demand for medical devices that incorporate tubing, drug delivery, dialysis and cardiac bypass, peristaltic pump, and sterile filling and dispensing systems, thereby driving the adoption of biopharmaceutical tubing systems.
Directly Purchase Premium Copy of Biopharmaceutical Tubing Market Growth Report (2021-2028) at: https://www.theinsightpartners.com/buy/TIPRE00008648
Global Biopharmaceutical Tubing Market Share Report, Segmentations, Regional & Country Scope:
| Report Coverage | Details |
| Market Size Value in | USD 3,442.82 Million in 2021 |
| Market Size Value by | USD 6,013.27 Million by 2028 |
| Growth rate | CAGR of 8.3% from 2021-2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
| No. of Pages | 174 |
| No. of Tables | 86 |
| No. of Charts & Figures | 70 |
| Historical data available | Yes |
| Segments covered | Type and Application |
| Regional scope | North America; Europe; Asia Pacific; Latin America; MEA |
| Country scope | US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Companies Covered | W. L. Gore and Associates, Saint-Gobain Sekurit, Freudenberg Group, RAUMEDIC AG, TEKNI-PLEX, NewAge Industries, Optinova, Zeus Industrial Products, NORDSON CORPORATION |
| Key Research Capabilities | Global Market Assessment, Business Development Strategies, Competitive Landscape, Opportunity Analysis, Regional and Country Level Market Analysis, Market Entry Strategies, Market Dynamics, Risk and Return Assessments, Pricing Analysis, Market Size and Forecasting, Company Profiling, Value Chain Analysis, Expansion Strategies, SWOT Analysis, New Product Development |
Browse key market insights spread across 174 pages with 86 list of tables & 70 list of figures from the report, “Biopharmaceutical Tubing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Plastic, Metal, and Silicone) and Application (Pharmaceutical {Single Use Technology, and Others, Medical Devices, Research and Development, and Others)” in detail along with the table of contents: https://www.theinsightpartners.com/reports/biopharmaceutical-tubing-market
Biopharmaceutical tubing are specifically designed to meet critical needs of biopharmaceutical and medical industries. This tubing is produced by the extrusion process and is extensively used in drug delivery systems, feeding tubes, and peristaltic pumps as well in a wide range of minimally critical invasive applications, including stent delivery systems, cardiovascular catheters, and urological retrieval devices. Moreover, these are also used with anesthesiology and respiratory equipment, IVs, and biopharmaceutical laboratory equipment. They confer exceptional thermal, mechanical, and chemical properties.
Companies are launching new and innovative products and services to sustain their position in the biopharmaceutical tubing market. In September 2021, DuPont introduced DuPont Liveo, a new brand name for its extensive range of silicone healthcare solutions. The Liveo brand product line includes pharma tubing and overmolded assemblies for single-use systems meant to be used in biopharma processing, transdermal and topical drug delivery systems, and medical adhesives, among others.
The COVID-19 pandemic is having the mixed impact on the biopharmaceutical tubing market. Growing COVID-19 infection in people with existing medical conditions such as asthma and diabetes also influences the growth of the market. There is a rise in the demand for drug delivery devices and equipment such as nasogastric tubes, nebulizers, spacer devices, etc. Therefore, these factors are driving the demand for biopharmaceutical tubing during the forecast period. On the other hand, many countries have changed medical device regulations owing to supply chain obstruction affect negatively on biopharmaceutical tubing market.
Based on type, the global biopharmaceutical tubing market is segmented into plastic, metal, and silicone. In 2020, the silicone segment held the largest share of the market. Moreover, the market for the silicone segment is expected to grow at the highest CAGR during 2021–2028. The biocompatibility of silicone allows it to be compatible with human tissues and body fluids, increasing its use in medical tubing as well as a silicone tube imparts properties such as biocompatibility, superior resistance to high temperatures and chemicals, mechanical strength, and electric properties. This factor is likely to boost the demand for biopharmaceutical tubing across the world during the forecast period.
Go through further research published by The Insight Partners: (Purchase with 10% Instant Discount):
Medical Tubing Market Forecast to 2028 - COVID-19 Impact and Global Analysis
Medical Polyimide Tubing Market Forecast to 2028 - COVID-19 Impact and Global Analysis
Medical Grade Tubing Market Forecast to 2028 - COVID-19 Impact and Global Analysis
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/biopharmaceutical-tubing-market